Literature DB >> 12645342

Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer.

James D Evans1, Philip A Cornford, Andrew Dodson, John P Neoptolemos, Christopher S Foster.   

Abstract

We immunohistochemically identified protein kinase C (PKC) isoenzymes and the receptor for activated C-kinase (RACK-1) in normal, chronically inflamed, and malignant pancreas specimens. Expression patterns were specific and consistent for each microanatomic structure. In chronic pancreatitis, the expression patterns by epithelial cells were indistinguishable from those in normal pancreas. In the stroma, there was a gain of PKC-delta (P < .05) and loss of PKC-mu (P < .0001). Expression in pancreatic duct carcinomas, compared with control normal minor ductular epithelial cells, revealed relative loss of PKC-epsilon (P < .0001), PKC-iota (P = .005), and PKC-theta (P < .0001) but no gain in any isoenzyme. Compared with control normal major duct epithelial cells, the principal differences were a relative loss in PKC-gamma (P < .05) and a relative gain in PKC-beta (P < .05), PKC-iota (P < .05), and PKC-zeta (P < .005). The stroma adjacent to ductal carcinomas was characterized by prominent expression of PKC-mu and a gain in PKC-delta (P < .0001) and PKC-zeta (P > .005). Ampullary carcinomas revealed a relative gain of PKC-iota (P < .05) and RACK-1 (P < .05). In the adjacent stroma was enhanced expression of PKC-delta (P < .005) and PKC-gamma (P < .001) and loss of PKC-mu (P < .05). Specific changes in isoenzyme expression in stroma of chronic pancreatitis and in epithelial cells and stroma of ductal and ampullary pancreatic adenocarcinomas reflect specific modulation of intracellular signaling pathways that control critical homeostatic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645342     DOI: 10.1309/bkpc9dx98r781b87

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

Review 1.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

2.  PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.

Authors:  Veronica Sancho; Marc J Berna; Michelle Thill; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2011-07-23

3.  Sublethal concentrations of the platinum(II) complex [Pt(O,O'-acac)(gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells.

Authors:  Antonella Muscella; Nadia Calabriso; Carla Vetrugno; Loredana Urso; Francesco Paolo Fanizzi; Sandra Angelica De Pascali; Santo Marsigliante
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis.

Authors:  Joao A Paulo; Vivek Kadiyala; Linda S Lee; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  J Proteome Res       Date:  2012-02-07       Impact factor: 4.466

Review 5.  Protein kinase C isoforms in the normal pancreas and in pancreatic disease.

Authors:  Alicia K Fleming; Peter Storz
Journal:  Cell Signal       Date:  2017-08-18       Impact factor: 4.315

Review 6.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

7.  Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.

Authors:  Elaine M Reno; James M Haughian; Irina K Dimitrova; Twila A Jackson; Kenneth R Shroyer; Andrew P Bradford
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

8.  Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells.

Authors:  Aaron C Spalding; Benjamin D Zeitlin; Kari Wilder-Romans; Mary E Davis; Jacques E Nor; Theodore S Lawrence; Edgar Ben-Josef
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

9.  Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.

Authors:  B L Allen-Petersen; C J Carter; A M Ohm; M E Reyland
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

Review 10.  Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators.

Authors:  Ling Huang; Senthil K Muthuswamy
Journal:  Curr Opin Genet Dev       Date:  2010-01-21       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.